| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 04/27/2010 | CA2435552C A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 04/22/2010 | WO2010043106A1 Injectable in-situ crosslinked hydrogel and the preparation method and use thereof |
| 04/22/2010 | CA2740136A1 Injectable in-situ crosslinked hydrogel and methods of making and using thereof |
| 04/21/2010 | EP2177212A1 Methods of using lamellar bodies for therapeutic purposes |
| 04/15/2010 | US20100093675 Novel method |
| 04/15/2010 | US20100092536 Implantable sensors and implantable pumps and anti-scarring agents |
| 04/15/2010 | US20100092533 Bioabsorbable Surgical Composition |
| 04/14/2010 | CN101693039A Medical composition for surgery washing |
| 04/14/2010 | CN101693024A Radionuclide-labelled biodegradable bioabsorbable biopolymer nano fibrous membrane, preparation process and application thereof |
| 04/06/2010 | US7691416 kit for administering a pharmaceutical composition that includes carbon monoxide to the patient in angioplasty procedures and for treating a donor, organ, and/or recipient with carbon monoxide during a transplantation procedure |
| 04/01/2010 | WO2010013231A3 Coagulation factor modulation for controlling transplant organ size |
| 04/01/2010 | US20100080838 Reactive Surgical Implant |
| 03/31/2010 | EP2168944A1 Amine compound and pharmaceutical use thereof |
| 03/31/2010 | EP2167105A1 Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film |
| 03/24/2010 | EP1813294B1 Adhesion preventive and method of preventing adhesion |
| 03/17/2010 | CN101669965A Application of PEG-PCL-PEG triblock copolymer in preparation of medical anti-adhesion material |
| 03/17/2010 | CN101669964A Surgery anti-adhesion agent and preparation method thereof |
| 03/16/2010 | US7678370 Methods of preventing peritonitis by administering lactic acid bacterium |
| 03/16/2010 | CA2372575C Bradykinin receptor antagonists |
| 03/09/2010 | US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/04/2010 | US20100056575 Anesthetic Compounds |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/24/2010 | EP2157093A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof |
| 02/24/2010 | EP1397167B1 Wound closure system and methods |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | US20100040688 Hydrogel microparticle formation in aqueous solvent for biomedical applications |
| 02/18/2010 | US20100040678 Organic compounds |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/16/2010 | US7662845 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 02/11/2010 | US20100034869 Block-polymer membranes for attenuation of scar tissue |
| 02/10/2010 | EP2150268A1 Compositions for prevention of adhesions and other barrier applications |
| 02/09/2010 | CA2625906C Lazaroids-based compositions and methods for preventing adhesion formation using the same |
| 02/09/2010 | CA2473394C Semi-fluorinated alkanes and their use |
| 02/09/2010 | CA2378976C Method of controlling body temperature while reducing shivering |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010013231A2 Modulation of coagulation factors and effectors of same for control of transplant organ size |
| 02/04/2010 | WO2009019260A3 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage |
| 02/04/2010 | US20100028309 Method for directed cell in-growth and controlled tissue regeneration in spinal surgery |
| 01/21/2010 | WO2010006634A1 Prevention and treatment of radiation injury |
| 01/21/2010 | WO2009129374A3 Methods and compositions for preventing adhesion |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015205 Biocompatible amino acid anhydride polymers |
| 01/21/2010 | US20100015114 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration |
| 01/14/2010 | US20100009408 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 01/08/2010 | CA2671115A1 Hydrogels suitable for use in polyp removal |
| 01/07/2010 | US20100003328 Bone filler for cartilage tissue regeneration treatment |
| 01/06/2010 | CN100577672C Ruthenium-anthraquinone conjugates, preparation method thereof and application for the same used as optical power therapeutic photosensitizer |
| 01/06/2010 | CN100577174C Compositions containing defined oxidized phospholipids |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 12/31/2009 | US20090325899 Medical composition for protuberance of epithelium |
| 12/31/2009 | US20090325878 Organ preconditioning, arrest, protection, preservation and recovery |
| 12/31/2009 | US20090325861 Dry wound dressing and drug delivery system |
| 12/31/2009 | US20090324680 Nanofiber-reinforced composition for application to surgical wounds |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | CA2367507C Angiogenesis using three-dimensional stromal tissue constructs |
| 12/24/2009 | DE10262084B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage |
| 12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | CA2727627A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions |
| 12/15/2009 | CA2295195C Compositions and methods for preventing restenosis following revascularization procedures |
| 12/09/2009 | CN101600460A Ultrasound microbubble mediated genes delivery system |
| 12/08/2009 | US7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies |
| 12/08/2009 | CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/02/2009 | EP2127659A1 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing |
| 12/02/2009 | CN100563680C Chinese medicine preparation for preventing and treating intestinal adhesion after abdominal cavity operation and its preparing process and application |
| 12/01/2009 | US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 11/25/2009 | EP2123287A1 Agent for preventing bleeding from cerebral cortical vein |
| 11/25/2009 | EP2120990A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 11/25/2009 | CN101584711A Nano-silver antibacterial washing fluid |
| 11/24/2009 | CA2264647C Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 11/24/2009 | CA2201105C Inhibitor of stem cell proliferation and uses thereof |
| 11/19/2009 | WO2009105165A3 Cardioplegia solution for cardiac surgery |
| 11/19/2009 | US20090285816 Albumin Fusion Proteins |
| 11/18/2009 | EP2119443A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 11/18/2009 | EP1458425B1 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 11/18/2009 | CN101579353A Temperature sensitive chitosan preparation and preparation and application thereof |
| 11/17/2009 | US7618941 Treating degenerative joint disorders with tribonectins |
| 11/10/2009 | CA2353642C Biocompatible crosslinked polymers |
| 11/05/2009 | WO2009133763A1 Visible medical treatment material |
| 11/05/2009 | US20090274741 Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same |
| 11/03/2009 | US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 10/29/2009 | US20090269316 Methods for Using a Three-Dimensional Stromal Tissue to Promote Angiogenesis |
| 10/27/2009 | CA2473393C Semi-fluorinated alkanes and their use |
| 10/22/2009 | WO2009129374A2 Methods and compositions for preventing adhesion |
| 10/22/2009 | US20090263456 Methods and Compositions for Reducing Preventing and Treating Adhesives |
| 10/13/2009 | US7601799 Methods and means to promote gut absorption |
| 10/13/2009 | CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 10/07/2009 | CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity |
| 10/01/2009 | WO2009085273A3 Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
| 10/01/2009 | WO2009085271A3 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
| 10/01/2009 | WO2009085268A3 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
| 10/01/2009 | US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 09/24/2009 | WO2009085269A3 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| 09/24/2009 | US20090238815 Nondegradable Hydrogels For Medical Device Application |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | US20090238792 Suppression of postoperative ileus |
| 09/22/2009 | CA2194476C Anti-adhesion agent |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |